I got it now.
It can still be used as vaccine (thereupatic) as it will kill the virus anyway.
The antibody is more preventing it from infecting in the first place.
The "not significant" part is more the 3rd party can't replicate the exact result; a disagreement.
Pretty good news, the antibody is extra that is good to have, but may not be needed anyway.
Ann: Admedus announces further data from HSV-2 Trial, page-51
-
- There are more pages in this discussion • 118 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.00 |
Change
0.150(1.01%) |
Mkt cap ! $317.0M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.15 | $14.30 | $210.2K | 14.26K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $14.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.00 | 5153 | 3 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |